144 related articles for article (PubMed ID: 3275060)
1. The role of the CA 125 assay in the management of ovarian cancer.
Niloff JM
Oncology (Williston Park); 1988 Aug; 2(8):67-76. PubMed ID: 3275060
[TBL] [Abstract][Full Text] [Related]
2. [The value of CA 125 determination in the serum of patients with ovarian cancer].
Bartel U; Johannsen B; Elling D
Zentralbl Gynakol; 1989; 111(5):301-9. PubMed ID: 2728673
[TBL] [Abstract][Full Text] [Related]
3. [Application of monoclonal antibody OC 125 in gynecological oncology].
Wu AR; Wang EY; Wang XX; Jia XH; Li L
Zhonghua Zhong Liu Za Zhi; 1988 Mar; 10(2):132-6. PubMed ID: 3208653
[TBL] [Abstract][Full Text] [Related]
4. Measurement of a monoclonal-antibody-defined antigen (90K) in the sera of patients with ovarian cancer.
Scambia G; Panici PB; Baiocchi G; Perrone L; Iacobelli S; Mancuso S
Anticancer Res; 1988; 8(4):761-4. PubMed ID: 3178164
[TBL] [Abstract][Full Text] [Related]
5. Preoperative serum tumor-associated antigen levels in women with pelvic masses.
Soper JT; Hunter VJ; Daly L; Tanner M; Creasman WT; Bast RC
Obstet Gynecol; 1990 Feb; 75(2):249-54. PubMed ID: 2300353
[TBL] [Abstract][Full Text] [Related]
6. Saliva and serum CA 125 assays for detecting malignant ovarian tumors.
Chen DX; Schwartz PE; Li FQ
Obstet Gynecol; 1990 Apr; 75(4):701-4. PubMed ID: 2179784
[TBL] [Abstract][Full Text] [Related]
7. Relationship between saliva and serum CA 125 in women with and without epithelial ovarian cancer.
Plante M; Wong GY; Nisselbaum JS; Almadrones L; Hoskins WJ; Rubin SC
Obstet Gynecol; 1993 Jun; 81(6):989-92. PubMed ID: 8497368
[TBL] [Abstract][Full Text] [Related]
8. [Results of CA-125 tumor marker determination in patients with ovarian carcinoma].
Miladinović D; Paunović R; Paunković N
Jugosl Ginekol Perinatol; 1989; 29(3-4):83-5. PubMed ID: 2601371
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of the tumor marker CA-125 for the preoperative diagnosis and postoperative management of patients with malignant ovarian cancers].
Sevelda P; Salzer H; Dittrich C; Spona J
Geburtshilfe Frauenheilkd; 1985 Nov; 45(11):769-73. PubMed ID: 3865860
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of CA 125 levels in differentiating malignant from benign tumors in patients with pelvic masses.
Chen DX; Schwartz PE; Li XG; Yang Z
Obstet Gynecol; 1988 Jul; 72(1):23-7. PubMed ID: 3164105
[TBL] [Abstract][Full Text] [Related]
11. Serological monitoring of epithelial ovarian cancer.
Fisken J; Leonard RC; Badley A; Jönrup I; Aspinall L; Sturgeon C; Roulston JE
Dis Markers; 1991; 9(3-4):175-90. PubMed ID: 1813209
[TBL] [Abstract][Full Text] [Related]
12. CA 125 in ovarian cancer.
van der Burg ME; Lammes FB; Verweij J
Neth J Med; 1992 Feb; 40(1-2):36-51. PubMed ID: 1579185
[TBL] [Abstract][Full Text] [Related]
13. [Significance of CA 125 antigen levels in patients with ovarian cancer].
Shimizu Y; Fujiwara H; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Okudaira Y
Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer.
Einhorn N; Sjövall K; Knapp RC; Hall P; Scully RE; Bast RC; Zurawski VR
Obstet Gynecol; 1992 Jul; 80(1):14-8. PubMed ID: 1603484
[TBL] [Abstract][Full Text] [Related]
15. CA 125 in monitoring chemotherapy of patients with ovarian cancer: early response to the treatment.
Markowska J; Kopczyński Z; Manyś G; Szewierski Z
Neoplasma; 1990; 37(6):687-92. PubMed ID: 2274087
[TBL] [Abstract][Full Text] [Related]
16. [Ovarian carcinoma antigen (CA 125) and ovarian cancer (clinical follow-up and prognostic studies)].
Göcze P; Vahrson H
Orv Hetil; 1993 Apr; 134(17):915-8. PubMed ID: 8479736
[TBL] [Abstract][Full Text] [Related]
17. CA 125 for the monitoring of ovarian carcinoma during primary therapy.
Lavin PT; Knapp RC; Malkasian G; Whitney CW; Berek JC; Bast RC
Obstet Gynecol; 1987 Feb; 69(2):223-7. PubMed ID: 2433652
[TBL] [Abstract][Full Text] [Related]
18. [Clinical use of CA-125 in gynecology. Preliminary experience].
Mayerson D; Badía J; Wild R; Barrena N; Johnson MC; Foradori A
Rev Chil Obstet Ginecol; 1989; 54(5):301-6. PubMed ID: 2490419
[TBL] [Abstract][Full Text] [Related]
19. Serum CA 125 levels in a group of nonhospitalized women: relevance for the early detection of ovarian cancer.
Zurawski VR; Broderick SF; Pickens P; Knapp RC; Bast RC
Obstet Gynecol; 1987 Apr; 69(4):606-11. PubMed ID: 2434895
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of cancer antigen 125 (CA 125) in ovarian cancer.
Crombach G; Zippel HH; Würz H
Cancer Detect Prev; 1985; 8(1-2):135-9. PubMed ID: 3864535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
